EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting toll-like receptor 4 (TLR4) and the NLRP3 inflammasome: Novel and emerging therapeutic targets for hyperuricaemia nephropathy

Chao Zhang, Yanlang Yang

Biomolecules and Biomedicine · 2023

DOI: 10.17305/bb.2023.9838 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules and Biomedicine, 2023. Verfasst von Chao Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Yijishan Hospital of Wannan Medical College, Wuhu, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Toll-Like Receptor 4, Hyperuricemia, Inflammasomes. Die Arbeit wurde bisher 33-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The clinical manifestation of hyperuricaemia, known as hyperuricaemia nephropathy, is relatively common. Its pathophysiology is largely based on chronic inflammation in circulatory and renal tissues. Toll-like receptor 4 (TLR4), a subclass of innate immune receptors, detects both pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs), initiating inflammatory and immune responses that lead to the release of pro-inflammatory cytokines interleukin 1 beta (IL-1β) and tumor necrosis factor alpha (TNF-α). These cytokines are pivotal in renal inflammation, especially in conditions like hyperuricaemia, acute renal injury, ischemia-reperfusion injury, and acute renal failure. The nucleotide-binding oligomerization domain (NOD)-like receptor pyrin domain-containing 3 (NLRP3) inflammasome, an essential component of the innate immune signaling complex, plays a central role in inflammation. It finely regulates the activation of caspase-1 and the production and secretion of the pro-inflammatory cytokine IL-1β, mediating and amplifying the inflammatory cascade response. Activation of TLR4 indirectly promotes the assembly of the NLRP3 inflammasome by regulating the nuclear factor kappa B (NF-κB) signaling pathway, thereby amplifying the inflammatory process and playing a significant pro-inflammatory role in hyperuricaemia nephropathy. TLR4 and NLRP3 inflammasome are anticipated to be novel markers and therapeutic targets for assessing treatment efficacy and prognosis in hyperuricaemia nephropathy. This paper provides a comprehensive overview of the structural composition and biological functions of TLR4 and NLRP3 inflammasome and systematically reviews their relevance in the pathogenesis of hyperuricaemia nephropathy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinToll-Like Receptor 4HyperuricemiaInflammasomesHumansAnimalsKidney DiseasesSignal Transduction

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinToll-Like Receptor 4InflammasomesNLRP3 protein, humanTLR4 protein, human

Autor:innen und Institutionen

  • Department of Nephrology, Yijishan Hospital of Wannan Medical College, Wuhu, China.

Zitieren

APA

Zhang, C., & Yang, Y. (2023). Targeting toll-like receptor 4 (TLR4) and the NLRP3 inflammasome: Novel and emerging therapeutic targets for hyperuricaemia nephropathy. Biomolecules and Biomedicine. https://doi.org/10.17305/bb.2023.9838

Vancouver

Zhang C, Yang Y. Targeting toll-like receptor 4 (TLR4) and the NLRP3 inflammasome: Novel and emerging therapeutic targets for hyperuricaemia nephropathy. Biomolecules and Biomedicine. 2023. doi:10.17305/bb.2023.9838

BibTeX
@article{Zhang2023,
  author = {Zhang, Chao and Yang, Yanlang},
  title = {Targeting toll-like receptor 4 (TLR4) and the NLRP3 inflammasome: Novel and emerging therapeutic targets for hyperuricaemia nephropathy},
  journal = {Biomolecules and Biomedicine},
  year = {2023},
  doi = {10.17305/bb.2023.9838}
}
Kostenlos starten →